Paid Clinical Trials in Lakewood, CO
As of September 2026, 74 paid clinical trials are recruiting in Lakewood, Colorado. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Lakewood offers studies at sites including CommonSpirit Saint Anthony Hospital Cancer Center for conditions such as Breast Cancer, Colorectal Neoplasms, Coronary Artery Disease, Geographic Atrophy (GA). Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Lakewood
Trials by drug in Lakewood
Filter results
73 clinical trials
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
Top Research Study Locations in Lakewood
Researchers run research studies in Lakewood, CO at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| CommonSpirit Saint Anthony Hospital Cancer Center | RISS Stage I Plasma Cell Myeloma, RISS Stage II Plasma Cell Myeloma, Acute Lymphoblastic Leukemia | 14 |
| Saint Anthony Hospital | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 10 |
| Colorado Clinical Research | Non-Muscle Invasive Bladder Neoplasms, Metastatic Castration-resistant Prostatic Neoplasms, Non-muscle Invasive Bladder Cancer | 8 |
| Rocky Mountain Cancer Centers, LLP | Colorectal Neoplasms, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma | 5 |
| Colorado Retina Associates | Geographic Atrophy (GA), Macular Edema, Neovascular (Wet) Age-Related Macular Degeneration | 5 |
| Rocky Mountain Cancer Centers-Lakewood | Acral Lentiginous Melanoma, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 4 |
| Colorado Urology | High-Risk Non-Muscle-Invasive Bladder Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC) | 3 |
| Rocky Mountain Cancer Centers LLP | Breast Cancer, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma | 2 |
| Advanced Urology | Non-muscle Invasive Bladder Cancer | 1 |
| Colorado Heart and Vascular | Coronary Artery Disease, Ischemic Heart Disease | 1 |
| Colorado Retina | Macular Telangiectasia Type 2 (MacTel) | 1 |
| Colorado Retina - Lakewood | Age-related Macular Degeneration (AMD), Geographic Atrophy (GA) | 1 |
| Colorado Retina Associates (RCA) | Neovascular Age-related Macular Degeneration, nAMD | 1 |
| Colorado Retina Associates, PLLC | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| Colorado Urology - St. Anthony Hospital Campus | Non-muscle Invasive Bladder Cancer With Carcinoma in Situ | 1 |
| Critical Care Pulmonary & Sleep Associates | Chronic Obstructive Pulmonary Disease | 1 |
| Critical Care Pulmonary and Sleep Associates (Ccpsa) - West Clinic | Idiopathic Pulmonary Fibrosis | 1 |
| GSK Investigational Site | Pulmonary Disease, Chronic Obstructive | 1 |
| Lakewood | Endometriosis, Uterine Fibroids | 1 |
| Local Institution - 007-872-A | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Local Institution - 0340 | Non-Small Cell Lung Cancer (NSCLC) | 1 |
| Rocky Mountain Cancer Center - Lakewood | Breast Cancer | 1 |
| Rocky Mountain Cancer Centers - Lakewood | Breast Cancer | 1 |
| Rocky Mountain Gastroenterology | Crohn's Disease | 1 |
| Rocky Mountain Gastroenterology (RMG) - Littleton | Chronic Idiopathic Constipation (CIC) | 1 |
Active & Upcoming Studies in Lakewood (2026)
Recruiting trials in Lakewood grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (39 active studies)
- Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer · Phase 2, Phase 3 · Pfizer
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
Eye & vision (7 active studies)
- A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration · Phase 3 · Amgen
- Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants · Phase 4 · Neurotech Pharmaceuticals
Cardiovascular (3 active studies)
- Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting · Philips Clinical & Medical Affairs Global
- Product Surveillance Registry · Medtronic
Neurology & pain (1 active study)
- Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase · University of Alabama, Tuscaloosa
Common conditions studied in Lakewood
- Breast Cancer (4 active studies)
- Colorectal Neoplasms (2 active studies)
- Coronary Artery Disease (2 active studies)
- Geographic Atrophy (GA) (2 active studies)
- Head and Neck Squamous Cell Carcinoma (2 active studies)
- Malignant Solid Neoplasm (2 active studies)
Leading research sponsors in Lakewood
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- Pfizer
- ECOG-ACRIN Cancer Research Group
- Janssen Research & Development, LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Lakewood?
There are approximately 74 recruiting clinical trials in Lakewood, Colorado listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lakewood pay participants?
Most recruiting trials in Lakewood compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lakewood?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lakewood?
The most common conditions under active study in Lakewood include Breast Cancer (4), Colorectal Neoplasms (2), Coronary Artery Disease (2), Geographic Atrophy (GA) (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lakewood?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lakewood on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lakewood?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lakewood?
Recruiting research sites in Lakewood include CommonSpirit Saint Anthony Hospital Cancer Center, Saint Anthony Hospital, Colorado Clinical Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lakewood right now?
The largest active categories in Lakewood are Cancer & tumors (39), Eye & vision (7), Cardiovascular (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.